Basics Evofem Biosciences, Inc. Evofem Biosciences Inc provides woman-controlled protection from sexually transmitted infections. It addresses women's unmet medical needs through the discovery, development and commercialization of healthcare products. IPO Date: November 20, 2014 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.97% Avg Daily Range (30 D): $0.01 | 25.00% Avg Daily Range (90 D): $0.01 | 37.50% Institutional Daily Volume Avg Daily Volume: 2.66M Avg Daily Volume (30 D): .59M Avg Daily Volume (90 D): .53M Trade Size Avg Trade Size (Sh.): 650 Avg Trade Size (Sh.) (30 D): 17,285 Avg Trade Size (Sh.) (90 D): 17,590 Institutional Trades Total Inst.Trades: 61 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $.5M Avg Inst. Trade (90 D): $.74M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.6M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 1.01K     News Nov 13, 2025 @ 9:05 PM Evofem Reports Financial Results for Third Quarter... Source: Prnewswire Oct 20, 2025 @ 8:19 PM Evofem Announces Voting Results from Special Meeti... Source: Prnewswire Oct 1, 2025 @ 12:47 PM Evofem's SOLOSEC Submitted for Marketing Approval ... Source: Prnewswire Sep 26, 2025 @ 12:15 PM Evofem Biosciences Honors World Contraception Day Source: Prnewswire Sep 11, 2025 @ 11:31 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Financials   TTM Q2 2022 Q1 2022 Basic EPS $.31 $-4.57 $-2.88 Diluted EPS $.31 $-4.57 $-2.88 Revenue $ .18M $ 6.03M $ 4.25M Gross Profit $ -.2M $ 4.75M $ 3.19M Net Income / Loss $ -8.34M $ -125.98M $ -31.89M Operating Income / Loss $ -12.05M $ -24.42M $ -28.93M Cost of Revenue $ .38M $ 1.29M $ 1.07M Net Cash Flow $ -5.07M $ 14.53M $ -5.86M PE Ratio 0.03     Splits May 18, 2023:   1:125 May 06, 2022:   1:15 Jan 18, 2018:   1:6